Elsevier

Experimental Cell Research

Volume 331, Issue 1, 1 February 2015, Pages 152-163
Experimental Cell Research

Research Article
Aldosterone up-regulates MMP-9 and MMP-9/NGAL expression in human neutrophils through p38, ERK1/2 and PI3K pathways

https://doi.org/10.1016/j.yexcr.2014.11.004Get rights and content

Highlights

  • Aldosterone increases MMP-9 and MMP-9/NGAL production by neutrophils.

  • This action is mediated by MR, PI3K, p38 and ERK1/2 pathways.

  • Mineralocorticoid receptors inhibitor reduced MMP-9 release.

  • Aldosterone likely regulates neutrophil functions.

Abstract

Aldosterone and mineralocorticoid receptors are important regulators of inflammation. During this process, chemokines and extracellular matrix degradation by matrix metalloproteases, such as MMP-9, help leukocytes reaching swiftly and infiltrating the injured tissue, two processes essential for tissue repair. Leukocytes, such as neutrophils, are a rich source of MMP-9 and possess mineralocorticoid receptors (MR). The aim of our study was to investigate whether aldosterone was able to regulate proMMP-9, active MMP-9 and MMP-9/NGAL production in human neutrophils. Here we show that aldosterone increased MMP-9 mRNA in a dose- and time-dependent manner. This hormone up-regulated also dose-dependently proMMP-9 and active MMP-9 protein release as well as the MMP-9/NGAL protein complex. PI3K, p38 and ERK1/2 inhibition diminished these aldosterone-induced neutrophil productions. Furthermore, spironolactone, a MR antagonist, counteracted aldosterone-induced increases of proMMP-9, active MMP-9 and MMP-9/NGAL complex. These findings indicate that aldosterone could participate in tissue repair by modulating neutrophil activity and favoring extracellular matrix degradation.

Introduction

Aldosterone is now recognized as a hormone implicated not only in homeostasis and blood pressure regulation but also in inflammation under physiopathological conditions. Results obtained from clinical data and animal models have demonstrated direct hypertrophic, thrombotic and fibrotic effects of aldosterone in organs such as heart and kidneys, and mineralocorticoid receptor (MR) antagonists diminish these harmful effects [1], [2], [3], [4]. Other data indicate that aldosterone plays an active role in vascular wall inflammation and its remodelling. This hormone promotes notably smooth muscle cell proliferation, NADPH oxidase activity, dysfunction and adhesion molecule increase in endothelial cells, leukocyte adhesion and infiltration [5], [6], [7], [8], [9]. Moreover, attenuation of atherosclerosis development by MR antagonists or aldosterone synthase inhibitors has been demonstrated [10], [11]. Accumulating data show that MR activation of immune cells, like macrophages, is also implicated in these events. Aldosterone increases monocyte/macrophage NADPH oxidase, NO and ROS production [12], [13]. Kidneys from rats infused with aldosterone present macrophage infiltration and spironolactone, a MR antagonist, counteracts this effect [14]. Specific deletion of MR from macrophages attenuates the hypertrophic and fibrotic effects, as well as the altered blood pressure normally observed in mice treated with deoxycorticosterone or l-NAME/AngII [15], [16], [17]. However, until now, neutrophils have received little attention despite the demonstration that these cells express mineralocorticoid receptors [18]. Moreover, neutrophils are the most abundant blood leukocytes and the first to arrive close to any inflamed tissue and to migrate through it. Activated neutrophils are then able to recruit other leukocytes such as monocytes and lymphocytes by chemokine and leukotriene secretion and help their diapedesis by pro-inflammatory cytokine and matrix metalloprotease (MMP) release [19]. Some chemokines such as CXCL8/IL-8, implicated in neutrophil oxidative bursts and chemotaxis, as well as pro-inflammatory cytokines like proIL-1β are cleaved by MMPs, such as MMP-9, into a biologically active form [20], [21]. Degradation of the extracellular matrix by collagenases, like MMP-2 and MMP-9, favors the entry of immune cells in altered tissue, which constitutes a prerequisite for tissue repair [22]. When activated, neutrophils are able to excrete large amounts of pro and active MMP-9 proteins. Cytokines such as IL-8, IL-1β and TNFα or the chemoattractant peptide formyl-Met-Leu-Phe are known to activate neutrophil MMP-9 release, corresponding to inflammatory or/and infectious conditions. A wide variety of other cells like astrocytes, chondrocytes, epithelial cells, fibroblasts, keratinocytes, mesangial cells, smooth muscle cells, and neurons are able also to secrete pro and active MMP-9 in response to cytokines such as IL-1β, TNFα and TGFβ [23], [24]. However, only neutrophils synthetize a protein complex termed “MMP-9/NGAL”, in which proMMP-9 is linked covalently to neutrophil gelatinase-associated lipocalin (NGAL) [25]. Approximately 20–30% of proMMP-9 is located in this complex where NGAL protects it from protease degradation [26].

Based on the above data, we hypothesized that aldosterone could regulate pro and active MMP-9 neutrophil production as well as that of the MMP-9/NGAL complex.

Herein, we show that aldosterone increases MMP-9 mRNA, proMMP-9, active MMP-9 and MMP-9/NGAL complex expression in granulocyte-differentiated HL-60 cells and in human neutrophils. This up-regulation is mediated by the activation of PI3kinase, p38 and to a lesser extent ERK1/2 pathways. Finally, we show that the MR antagonist, spironolactone, counteracts aldosterone effects on MMP-9 mRNA, proMMP-9, active MMP-9 and MMP-9/NGAL complex.

Section snippets

Cell culture and treatments

The HL-60 human leukemia cell line was cultured at 37 °C under 5% CO2 in RPMI 1640 medium containing 10% heat inactivated fetal calf serum (Eurobio, Courtaboeuf, France), 100 U/mL penicillin, 100 μg/mL streptomycin, 10 mM Hepes, 2 mM l-glutamine, 1 mM sodium pyruvate (all purchased from Sigma-Aldrich) and 1× non-essential amino-acids (Gibco-BRL, Invitrogen, Baisley, UK). HL-60 cells were differentiated into the neutrophil-lineage by adding 1.3% of DMSO during three days and then 0.65% of DMSO for

Effect of aldosterone on MMP-9 mRNA levels in HL-60 and human PMN

Differentiated HL-60 cells were incubated with aldosterone 10−7, 10−8 or 10−9 M for different time periods. As shown in Fig. 1A, aldosterone upregulated MMP-9 mRNA expression in HL-60 cells in a time- and dose-dependent manner. Indeed, this increase appeared already after 1 h 30 min of incubation and peaked at 6 h. Furthermore, at 6 h, MMP-9 mRNA levels had increased 10-, 6.1- and 3.7-fold with aldosterone at 10−7, 10−8 and 10−9 M, respectively, compared to unstimulated cells. In order to verify that

Discussion

Little information exists about potential regulation of neutrophil functions by aldosterone and MR despite the fact that neutrophils are the most abundant leukocytes and are present in altered tissue from the onset to the end of inflammation/repair. Matrix metalloproteases (MMPs) play an important role during inflammation by degrading extracellular matrix components but also, in the case of MMP-9, by cleaving VEGF-A and some chemokines into biologically active forms useful, respectively, for

Source funding

This work was financially supported by the Fondation de France.

Acknowledgments

We would like thank Dr V. Latger-Cannard and M. Siest (Department of Biological Haematology, Centre Hospitalier Universitaire, Vandoeuvre-les-Nancy, France) for human healthy volunteers recruitment and for blood drawings. We are also grateful to Dr S. Grandemange (Faculty of Sciences, Vandoeuvre les Nancy, France) for performing annexin V studies.

References (53)

  • S. Kim et al.

    EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line

    Cell Signal.

    (2009)
  • S. Mitra et al.

    Participation of superoxide in neutrophil activation and cytokine production

    Biochim. Biophys. Acta

    (2006)
  • P.Y. Coxon et al.

    MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils

    Cell Signal.

    (2003)
  • G. Christoffersson et al.

    VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue

    Blood

    (2012)
  • R. El Bekay et al.

    Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB

    Blood

    (2003)
  • R.W. Guo et al.

    Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells

    Regul. Pept.

    (2008)
  • R. Rocha et al.

    Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats

    Hypertension

    (1999)
  • Y. Sun et al.

    Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion

    Cardiovasc. Res.

    (1997)
  • B. Pitt et al.

    The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

    N. Engl. J. Med.

    (1999)
  • R. Yamanaka et al.

    Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension

    Hypertens. Res.

    (2010)
  • C.A. Farquharson et al.

    Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy

    Clin. Sci.

    (2002)
  • U. Hillebrand et al.

    Dose-dependent endothelial cell growth and stiffening by aldosterone: endothelial protection by eplerenone

    J. Hypertens.

    (2007)
  • M. Caprio et al.

    Functional mineralocorticoid receptors in human vascular endothelial cells regulate ICAM-1 expression and promote leukocyte adhesion

    Circ. Res.

    (2008)
  • S. Takai et al.

    Eplerenone inhibits atherosclerosis in nonhuman primates

    Hypertension

    (2005)
  • A. Gamliel-Lazarovich et al.

    FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient mice

    J. Hypertens.

    (2010)
  • S. Keidar et al.

    Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone

    Circulation

    (2004)
  • Cited by (0)

    View full text